ms contin® tablets (Purdue Frederick Company)
90
Structured Review
Purdue Frederick Company
ms contin® tablets
Ms Contin® Tablets, supplied by Purdue Frederick Company, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/ms+contin+tablets/ms+contin/us08685994-22-30-39
Average 90 stars, based on 1 article reviews
Ms Contin® Tablets, supplied by Purdue Frederick Company, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/ms+contin+tablets/ms+contin/us08685994-22-30-39
Average 90 stars, based on 1 article reviews
ms contin® tablets - by Bioz Stars,
2026-11
90/100 stars
Images
Related Articles
other:Article Title: Analgesic combination of oxycodone and celecoxib Article Snippet: Morphine, which has been considered the prototypic opioid analgesic, has been available in many dosage forms, including immediate release oral dosage forms, and more recently, formulated into 12 hour controlled Article Title: Method of treating humans with opioid formulations having extended controlled release Article Snippet: Morphine, which is considered to be the prototypic opioid analgesic, has been formulated into 12 hour Article Title: Intrathecal therapy for cancer and nonmalignant pain: patient selection and patient management. Article Snippet: Intrathecal Therapy for Cancer and Nonmalignant Pain: Patient Selection and Patient Management Timothy Deer, MD* ▪ Wolfhard Winkelmu ̈ ller, MD‡ ▪ Serdar Erdine, MD‡ ▪ Marshall Bedder, MD§ ▪ Kim Burchiel, MD¶ *The Center for Pain Relief, Charleston, West Virginia, USA; ‡Gemeinschaftspraxis fu ̈ r Neurochirurgie, Hannover, Germany; ‡Department of Algology, Medical Faculty of Istanbul, Istanbul, Turkey; §Advanced Pain Management Group, Inc., Portland, Oregon, USA; ¶Oregon Article Title: The marketing of OxyContin®: A cautionary tale Article Snippet: This paper provides a review of Purdue Pharma, LP’s development and marketing of the long-acting oral narcotic OxyContin®.. Within five years of the drug’s launch, OxyContin® became the number-one prescribed Schedule II narcotic in the United States.. This commercial success was in part the result of a marketing campaign that promoted questionably “distinctive” benefits The marketing of OxyContin®: A cautionary tale DAVID S EGILMAN, GREGORY B COLLINS, JULIE FALENDER, NAOMI SHEMBO, CIARA KEEGAN, SUNIL TOHAN Authors: David S Egilman (corresponding author — degilman@egilman. com), Never Again Consulting, Attleboro, MA 02703, and Clinical Professor of Family Medicine, Alpert School of Medicine, Brown University, Providence, RI 02903, USA; Gregory B Collins (drgbcollins@yahoo.com), Staff Psychiatrist and Former Medical Director, Department of Behavioral Health, Moore Regional Hospital, Pinehurst, NC 28374, USA; Julie Falender (jfalender@ gmail.com), Never Again Consulting, Attleboro, MA 02703, USA; Naomie Shembo (naomie_shembo@brown.edu), Brown University, Providence, RI 02912, and Never Again Consulting, Attleboro, MA 02703, USA; Ciara Keegan (ciara_keegan@brown.edu), Brown University, Providence, RI 02912, and Never Again Consulting, Attleboro, MA 02703, USA; Sunil Tohan (sunil_ tohan@brown.edu), Brown University, Providence, RI 02912, and Never Again Consulting, Attleboro, MA 02703, USA. Targeted Proteomics:Article Title: A comparative study of 2 sustained-release morphine preparations for pain in advanced cancer. Article Snippet: Purpose: Several sustained-release morphine (SRM) formulations are available internationally.. This study compared 2 such products available in the United States, SR1 and SR2.. Patients and Methods: In an open-label study, patients with advanced cancer pain were randomized to receive SR1 or SR2 every 12 hours around-the-clock (ATC) for 5 days, with immediate release (IR) liquid morphine for rescue dosing (RD). Control:Article Title: A comparative study of 2 sustained-release morphine preparations for pain in advanced cancer. Article Snippet: Purpose: Several sustained-release morphine (SRM) formulations are available internationally.. This study compared 2 such products available in the United States, SR1 and SR2.. Patients and Methods: In an open-label study, patients with advanced cancer pain were randomized to receive SR1 or SR2 every 12 hours around-the-clock (ATC) for 5 days, with immediate release (IR) liquid morphine for rescue dosing (RD). |
